Finding fragments that bind to such targets is straight-forward. For most kinases, a screen of our 1350 member fragment library results in between 40 to 170 validated and chemically distinct hits. In addition, crystal structures for these hits bound to the kinase can usually be obtained quite rapidly. The real challenge is how to digest all this information and decide how and which fragments to progress in order to identify the highest quality leads. My presentation will illustrate the approach taken at Vernalis in some recent projects which led to the discovery of novel lead series for a number of different kinases. The main messages are that: fragments always tell you something new about the binding site; careful triage and exploration of fragment SAR can give indications of how to achieve selectivity, novelty and affinity;it is important to optimise the fragment before investing large chemistry resources and that with patience, a fragment derived series will often supersede an HTS derived series and deliver a better quality of compound for lead optimisation.
Choosing & Using Fragments in the Generation of Selective Kinase Inhibitors
Video Apr 23, 2015
Behind the Science, S2 Ep 10: Kari Organtini on options for analyzing pesticides with GC-MS/MSVideo
Senior scientist Kari Organtini shows Jen Fournier an increasingly popular technology that uses GC-MS/MS at atmospheric pressure - or APGC - and is available as a simple source change for a triple quadrupole mass spectrometer so the MS can be used with either GC or LC.WATCH NOW
Multi-Analyte Mass Spectrometry Software for Faster Quantitative Analysis and Higher ProductivityVideo
Shimadzu's LabSolutions Insight Software for LC-MS/MS and GC/MS provides powerful data mining and analytics capabilities.WATCH NOW